GlassScriptPhysician profile
Sateesh Kotturi
NPI 1962899328
$1,629.29
in general payments reported to CMS, 2019-2025
21 companies · $184 in 2025
The $184 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $184 · 2020: $92.95 · 2021: $172 · 2022: $156 · 2023: $466 · 2024: $375 · 2025: $184.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,025.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,024.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $388.19 | 2023-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Janssen Pharmaceuticals, INC | $331.57 | 2020-2024 | Xarelto |
| Merck Sharp & Dohme LLC | $178.14 | 2019-2024 | Dificid, Recarbrio, Zerbaxa |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $157.67 | 2020-2025 | Xifaxan |
| Pfizer INC. | $83.33 | 2019-2022 | |
| Alexion Pharmaceuticals, INC. | $79.06 | 2019-2023 | Ultomiris |
| Melinta Therapeutics, LLC | $68.86 | 2024-2025 | Rezzayo, Orbactiv, Kimyrsa |
| Vifor Pharma, INC. | $42.05 | 2019 | |
| Janssen Scientific Affairs, LLC | $35.56 | 2023 | Xarelto |
| Abbvie INC. | $32.99 | 2021-2022 | |
| Allergan, INC. | $28.67 | 2019 | |
| Insmed, INC. | $27.25 | 2025 | Arikayce |
| Stryker Corporation | $23.51 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Otsuka America Pharmaceutical, INC. | $23.11 | 2019 | |
| Gilead Sciences, INC. | $21.81 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $20.27 | 2023 | Repatha |
| Urgo Medical North America, LLC | $19.70 | 2024 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Alkermes, INC. | $18.47 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $17.15 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $16.97 | 2023 | Camzyos |
| Bioxcel Therapeutics, INC. | $14.96 | 2023 | Igalmi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sateesh Kotturi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.